The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- Artificial Intelligence in Dentistry: Why Dental Schools Must Reinvent Dental Education
- Daoism and Dentistry: Finding Natural Balance in TMJ Disorders
- Silver Diamine Fluoride: A New Approach to Caries Management
- India’s Proposed National Dental Implant Safety Framework: A Timely Step Towards Safer Implant Dentistry
- Why Every Dentist Should Understand Generative AI and Bloom’s Taxonomy
Archives